VZL 2007, 76(4):158-161

Epidemiological Risks of Vaccination against Variola at the Present Time: Contact Transmission of Vaccinia virus

Miroslav Špliňo ORCID..., Roman Prymula ORCID..., Roman Chlíbek ORCID...
Univerzita obrany, katedra epidemiologie Fakulty vojenského zdravotnictví, Hradec Králové

Autoři popisují současný stav vakcinace proti variole v mimoepidemickém období. Jsou uvedeny indikační kritéria, doporučená vakcinace pro osoby pracující s virem vaccinie. Je uvedena kazuistika závažné komplikace eczema vaccinatum po kontaktním přenosu viru vaccinie z otce na syna (vakcinovaný příslušník armády).

Keywords: Variola; Virus vaccinie; Eczema vaccinatum; Bioterorismus

The authors describe the present state of vaccination against variola in the non-epidemic period. They put forward the indication criteria, the recommended vaccination for persons working with vaccinia virus, and the case description of a severe complication of eczema vaccinatum after contact transmission of vaccinia virus from father to son (vaccinated army member).

Keywords: Variola; Vaccinia virus; Eczema vaccinatum; Bioterorism

Received: April 16, 2007; Published: December 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Špliňo, M., Prymula, R., & Chlíbek, R. (2007). Epidemiological Risks of Vaccination against Variola at the Present Time: Contact Transmission of Vaccinia virus. Vojenské Zdravotnické Listy76(4), 158-161
Download citation

References

  1. Vaccinia (Smallpox) Vaccine Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001.
  2. FENNER, F. - HENDERSON, DA. - ARITA, I., et al. Smallpox and its eradication. Switzerland, Geneva, World Health Organization, 1988.
  3. HENDERSON, DA. - INGLESBY, TV. - BARTLETT, JG., et al. Smallpox as a biological weapon: medical and public health management. JAMA, 1999, vol. 281, p. 2127-2137. Go to original source... Go to PubMed...
  4. CDC. Vaccinia (smallpox) vaccine: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR, 1991, vol. 40 (RR-14), p. 1-10. Erratum: MMWR, 1992, vol. 41, p. 31.
  5. COONEY, EL. - COLLIER AC. - GREENBERG PD., et al. Safety and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein. Lancet, 1991, vol. 337, p. 567-572. Go to original source... Go to PubMed...
  6. GARNER, JS. The Hospital Infection Control Practices Advisory Committee. Guideline for isolation precautions in hospitals. Infect. Control. Hosp. Epidemiol., 1996, vol. 17, p. 5-80. Go to original source... Go to PubMed...
  7. Advisory Committee on Dangerous Pathogens, Advisory Committee on Genetic Modification. Vaccination of laboratory workers handling vaccinia and related poxviruses infectious for humans. United Kingdom, 1990.
  8. KOPLAN, JP. - MARTON, KI. Smallpox vaccination revisited. Some observations on the biology of vaccinia. Am. J. Trop. Med. Hyg., 1975, vol. 24, no. 4, p. 656-663. Go to original source... Go to PubMed...
  9. CDC. Contact spread of vaccinia from a recently vaccinated Marine - Louisiana. MMWR, 1984, vol. 33, p. 3-8.
  10. CDC. Epidemiologic notes and reports: contact spread of vaccinia from a National Guard vaccinee - Wisconsin. MMWR, 1985, vol. 34, p. 182-183.